Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib and Bevacizumab in Advanced Melanoma and Other Cancers
NCT00074308Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2003
- Primary completion
- Jul 2009
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib, bevacizumab in melanoma, solid tumor, sponsored by National Cancer Institute. Started Oct 2003; status: completed.
02
Drugs
imatinibbevacizumab
03
Conditions
melanomasolid tumor
Beyond the preview
Go deeper on NCT00074308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00074308.